Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Immunoassay Analyzers Market: By Product, By Application, By Based on End User, and Geography
Immunoassay Analyzers Market: By Product, By Application, By Based on End User, and Geography
Immunoassay Analyzers Market size was valued at US$ 39.5 billion in 2023, at a CAGR of 5.2% from 2024-2030. Immunoassay analyzers are the instruments that are used in clinical settings, hospitals, or maybe research organizations to run biochemical tests to detect the concentration of samples. The market for immune analyzers is growing due to the increased prevalence of disease outbreaks such as Zika and the rising incidence of chronic diseases such as hepatitis. Furthermore, advances in laboratory automation and integration, as well as preventative healthcare, are creating prospects for the global immunoassay analyzers market growth. Immunoassay analyzers are extensively used in clinical laboratories and hospitals to perform biochemical tests aimed at detecting and measuring the quantity of chemicals in samples. Small-scale laboratories have a long time to adjust to changes in instrumentation due to factors such as system revaluation, staff training, procedure standardization, and lengthy purchase processes. Manufacturers, on the other hand, are seeking to make more affordable analyzer systems or provide replacement benefits to create revenue. Companies operating in the global immune analyzers market are focusing on new product developments and launches to strengthen their position.
Study Period
2024-2030Base Year
2023CAGR
5.2%Largest Market
North AmericaFastest Growing Market
Asia-Pacific
immune analyzers market is primarily driven by adaptation of the automated instruments in the research and other commercial organizations, especially in developed countries. In addition, growing prevalence of the chronic conditions, infectious diseases and R&D investments in biotechnological companies around the world. Furthermore, advancements in the immune analyzers such as advent of portable immune assay analyzers and new product launches are expected to boost the market growth over the forecast period. However, high cost of devices and lack of skilled professionals are expected to hamper the market growth over the forecast period.
Geographically, global immuno analyzers market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America immune analyzers market is expected to grow at notable rates owing to the technological advancements and presence of key market players in the region. In addition, recent product launches and collaboration of various organizations in advancing the biotechnology to diagnose and treat diseases projected to boost the market share in the region. For Instance, Abbot Laboratories has launched Automated Immunoassay instrument Architect i1000SR. Europe immune analyzers market projected to have significant market share due to the presence of key market players and adaptation of automated instruments and increased fundings in biotechnological firms. Asia Pacific region projected to have lucrative market growth opportunity owing to the increase in the prevalence of chronic and infectious diseases. The countries such as India and China expected to contribute significant share in regional market owing to increase in the R&D investment by the companies and adaptation of automated instruments in many organizations
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 39.5 billion |
|
Market CAGR |
5.2% |
|
By Product Type |
|
|
By Application |
|
|
By End User |
|
Download Free Sample Report
The immunoassay analyzers market size was valued at US$ 39.5 billion in 2023
The immunoassay analyzers market key players are: Abbott BD Beckman Coulter, Inc. Bio-Rad Laboratories, Inc. bioMrieux SA Biokit S.A. DiaSorin S.p.A. Hoffmann-La Roche Ltd. Immunodiagnostic Systems Luminex Corporation Merck KGaA Nova Century Scientific, Inc. Olympus Corporation Ortho Clinical Diagnostics Quidel Corporation Randox Laboratories Ltd. Siemens Tecan Trading AG The Binding Site Group Ltd. Thermo Fisher Scientific, Inc.
The immunoassay analyzers market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
| 1. Executive Summary |
| 2. Global Immunoassay Analyzers Market Introduction |
| 2.1.Global Immunoassay Analyzers Market - Taxonomy |
| 2.2.Global Immunoassay Analyzers Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Application |
| 2.2.3.End Users |
| 2.2.4.Region |
| 3. Global Immunoassay Analyzers Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global Immunoassay Analyzers Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Immunoassay Analyzers Market By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Chemiluminescence Immunoassay Analyzers |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Radioimmunoassay Analyzers |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Immunofluorescence Analyzers |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. ELISA Analyzers |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Consumable |
| 5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 6. Global Immunoassay Analyzers Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Oncology |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Therapeutic Drug Monitoring |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Cardiology |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Autoimmune Disease |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Infectious Disease Testing |
| 6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7. Global Immunoassay Analyzers Market By End Users, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Biotechnological Firms |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Research Organizations |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Diagnostic Centers |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Others |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8. Global Immunoassay Analyzers Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9. North America Immunoassay Analyzers Market,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Chemiluminescence Immunoassay Analyzers |
| 9.1.2.Radioimmunoassay Analyzers |
| 9.1.3.Immunofluorescence Analyzers |
| 9.1.4.ELISA Analyzers |
| 9.1.5.Consumable |
| 9.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Oncology |
| 9.2.2.Therapeutic Drug Monitoring |
| 9.2.3.Cardiology |
| 9.2.4.Autoimmune Disease |
| 9.2.5.Infectious Disease Testing |
| 9.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Biotechnological Firms |
| 9.3.2.Research Organizations |
| 9.3.3.Diagnostic Centers |
| 9.3.4.Others |
| 9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10. Europe Immunoassay Analyzers Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Chemiluminescence Immunoassay Analyzers |
| 10.1.2.Radioimmunoassay Analyzers |
| 10.1.3.Immunofluorescence Analyzers |
| 10.1.4.ELISA Analyzers |
| 10.1.5.Consumable |
| 10.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Oncology |
| 10.2.2.Therapeutic Drug Monitoring |
| 10.2.3.Cardiology |
| 10.2.4.Autoimmune Disease |
| 10.2.5.Infectious Disease Testing |
| 10.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Biotechnological Firms |
| 10.3.2.Research Organizations |
| 10.3.3.Diagnostic Centers |
| 10.3.4.Others |
| 10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 11. Asia Pacific (APAC) Immunoassay Analyzers Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Chemiluminescence Immunoassay Analyzers |
| 11.1.2.Radioimmunoassay Analyzers |
| 11.1.3.Immunofluorescence Analyzers |
| 11.1.4.ELISA Analyzers |
| 11.1.5.Consumable |
| 11.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Oncology |
| 11.2.2.Therapeutic Drug Monitoring |
| 11.2.3.Cardiology |
| 11.2.4.Autoimmune Disease |
| 11.2.5.Infectious Disease Testing |
| 11.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Biotechnological Firms |
| 11.3.2.Research Organizations |
| 11.3.3.Diagnostic Centers |
| 11.3.4.Others |
| 11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12. Middle East and Africa (MEA) Immunoassay Analyzers Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Chemiluminescence Immunoassay Analyzers |
| 12.1.2.Radioimmunoassay Analyzers |
| 12.1.3.Immunofluorescence Analyzers |
| 12.1.4.ELISA Analyzers |
| 12.1.5.Consumable |
| 12.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Oncology |
| 12.2.2.Therapeutic Drug Monitoring |
| 12.2.3.Cardiology |
| 12.2.4.Autoimmune Disease |
| 12.2.5.Infectious Disease Testing |
| 12.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Biotechnological Firms |
| 12.3.2.Research Organizations |
| 12.3.3.Diagnostic Centers |
| 12.3.4.Others |
| 12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13. Latin America Immunoassay Analyzers Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Chemiluminescence Immunoassay Analyzers |
| 13.1.2.Radioimmunoassay Analyzers |
| 13.1.3.Immunofluorescence Analyzers |
| 13.1.4.ELISA Analyzers |
| 13.1.5.Consumable |
| 13.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Oncology |
| 13.2.2.Therapeutic Drug Monitoring |
| 13.2.3.Cardiology |
| 13.2.4.Autoimmune Disease |
| 13.2.5.Infectious Disease Testing |
| 13.3. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Biotechnological Firms |
| 13.3.2.Research Organizations |
| 13.3.3.Diagnostic Centers |
| 13.3.4.Others |
| 13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Abbott |
| 14.2.2.BD |
| 14.2.3.Beckman Coulter, Inc. |
| 14.2.4.Bio-Rad Laboratories, Inc. |
| 14.2.5.bioMrieux SA |
| 14.2.6.Biokit S.A. |
| 14.2.7.DiaSorin S.p.A. |
| 14.2.8.Hoffmann-La Roche Ltd. |
| 14.2.9.Immunodiagnostic Systems |
| 14.2.10.Luminex Corporation |
| 14.2.11.Merck KGaA |
| 14.2.12.Nova Century Scientific, Inc. |
| 14.2.13.Olympus Corporation |
| 14.2.14.Ortho Clinical Diagnostics |
| 14.2.15.Quidel Corporation |
| 14.2.16.Randox Laboratories Ltd. |
| 14.2.17.Siemens |
| 14.2.18.Tecan Trading AG |
| 14.2.19.The Binding Site Group Ltd. |
| 14.2.20.Thermo Fisher Scientific, Inc. |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.